A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years

by Craig I. Coleman Pharma D, FASHP, FACC, Olivia S. Costa PharmD, Christopher W. Brescia BS, Burcu Vardar MD, Khaled Abdelgawwad MSc, Lucas Hofmeister PhD, Nitesh Sood MD
Published 2022-11-01

Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis

by Craig I. Coleman PharmD, Reinhold Kreutz MD, PhD, Nitesh Sood MD, Thomas J. Bunz PharmD, PhD, Anna-Katharina Meinecke PhD, Daniel Eriksson MSc, William L. Baker PharmD
Published 2019-08-01